Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Yomeishu Seizo Co., Ltd. ( (JP:2540) ) has issued an announcement.
Yomeishu Seizo has warned it will book significant extraordinary losses for the fiscal year ending March 31, 2026, driven by about ¥380 million in tender offer-related advisory and legal costs and a ¥2.93 billion impairment on underperforming CLASUWA-related assets. As a result, the company has sharply revised its non-consolidated net income forecast from a ¥840 million profit to a ¥1.64 billion loss, and decided to cut its year-end dividend for fiscal 2026 to zero, terminate its shareholder benefit program from fiscal 2027, and abandon its mid-term management plan, moves that underscore a major strategic reset as it supports a tender offer that is expected to lead to delisting and a shift to a single controlling shareholder.
The board has expressed support for the tender offer by Reno Co., Ltd., which aims to reduce Yomeishu’s shareholder base to a single stakeholder, TSUMURA & CO., implying a transition away from the public market and potentially reshaping governance and capital policy. These changes signal heightened short-term financial pressure and the end of existing shareholder return frameworks, with material implications for minority investors as the company reorients its strategy under an anticipated new ownership structure.
The most recent analyst rating on (JP:2540) stock is a Hold with a Yen4449.00 price target. To see the full list of analyst forecasts on Yomeishu Seizo Co., Ltd. stock, see the JP:2540 Stock Forecast page.
More about Yomeishu Seizo Co., Ltd.
Yomeishu Seizo Co., Ltd. is a Japan-based beverage and health-related products manufacturer best known for its traditional herbal liqueurs and related offerings. The company is listed on the Tokyo Stock Exchange Prime Market under securities code 2540 and operates primarily in the domestic Japanese market, where it targets consumers seeking health-oriented alcoholic and functional beverages.
Average Trading Volume: 55,940
Technical Sentiment Signal: Buy
Current Market Cap: Yen61.72B
For a thorough assessment of 2540 stock, go to TipRanks’ Stock Analysis page.